757 results on '"Felker, G"'
Search Results
2. Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF
3. Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study
4. Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study
5. Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials
6. Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
7. Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial
8. The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF
9. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
10. Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways
11. Electronic health record characterization and outcomes of heart failure with preserved ejection fraction
12. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
13. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
14. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
15. Natriuresis-Guided Titration of Loop Diuretics in Heart Failure: Another Brick in the Wall
16. Medication-Attributable Adverse Events in Heart Failure Trials
17. Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure
18. Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan
19. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
20. Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status
21. Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
22. A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes
23. Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week
24. Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction
25. Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials.
26. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
27. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
28. Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study
29. Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction
30. Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes
31. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
32. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
33. Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study
34. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure
35. Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
36. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure
37. Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy
38. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
39. Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure
40. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
41. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
42. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
43. Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
44. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
45. Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction
46. Severe obesity among patients with left ventricular assist devices.
47. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2
48. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
49. In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States
50. Splanchnic Nerve Block for Chronic Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.